Sanyo Chemical Industries, Ltd.
Mid-Term Management Plan 2030 “Accelerating Transformation” ~ Enhancing Speed and Delivering Value ~
Sanyo Chemical Industries has formulated the Mid-Term Management Plan 2030, aiming for consolidated operating profit of 20 billion yen and ROE of 8% or more by 2030, promoting growth strategies and structural reforms.
Key Figures
- Sales target for 2030: 160 billion yen
- Operating income target for 2030: 20 billion yen
- ROE target for 2030: 8% or more
AI要約
Overview of the Mid-Term Management Plan 2030
Sanyo Chemical Industries adopted the Mid-Term Management Plan 2030 at the Board of Directors meeting held on May 13, 2026, setting 2030 as the final year of a five-year plan. The plan articulates a long-term vision of "Becoming an Essential Company that Sparks Innovation at Interfaces," updating the mission and values. Focus areas have been reorganized into "Core Materials," "Wellness," and "ICT" to pursue sustainable growth and enhanced profitability. Quantitative goals for 2030 include sales of 160 billion yen, operating income of 20 billion yen, an operating profit margin of 12% or more, net income of 14 billion yen, ROE of 8% or more, and ROIC of 7% or more.
Growth Strategies and Strengthening of Business Foundations
The growth strategy emphasizes the establishment of a new healthcare company in the U.S., development and creation of high-value-added products, and nurturing new businesses. Structural reforms include consolidation and rationalization of production facilities and optimizing manufacturing through digitalization. To reinforce management foundations, strategies for digital utilization, human resources, and R&D are outlined to enhance speed and value creation. Additionally, the shareholder return policy will be revised, targeting a comprehensive payout ratio of over 40%, with gradual dividend increases and flexible share buybacks.
Sanyo Chemical Industries, Ltd.
Company overview · Stock price · Financial data · All IR